Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
PULMONX CORP
About LUNG
Pulmonx Corporation is a commercial-stage medical technology company. The Company provides minimally invasive treatments for chronic obstructive pulmonary disease (COPD). The Company’s Zephyr Endobronchial Valve, Chartis Pulmonary Assessment System, LungTraX Platform, and StratX Lung Analysis Report are designed to assess and treat patients with severe emphysema/COPD. The LungTraX Platform is a cloud-based quantitative CT (QCT) analysis service that provides physicians with multiple products, LungTraX Connect, to improve workup efficiency, LungTraX Detect, to enable patient identification and an easy-to-read StratX Lung report that it designed for its solution that includes information on emphysema destruction, fissure completeness and lobar volume to help identify target lobes for treatment with Zephyr Valves. The Chartis System is a proprietary balloon catheter and console system with flow and pressure sensors designed to assess the presence of collateral ventilation.
Find out what a historical investment in PULMONX CORP would be worth today using our LUNG stock calculator.
Market Capitalisation
$53.64M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
275.28K
High today
$1.33
Low today
$1.25
Open price
$1.33
52-week high
$3.88
52-week low
$1.13
Ready to start your investing journey with Stake?
Open an accountHow do I buy LUNG shares in Australia?
Buying LUNG shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in PULMONX CORP in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in LUNG
What is the ticker symbol of PULMONX CORP?
The ticker symbol for PULMONX CORP is LUNG.
How much is one share of LUNG?
One share of LUNG is valued at $1.28 as of 16 May 2026.
What is the market capitalisation of PULMONX CORP LUNG?
As of 16 May 2026 PULMONX CORP has a market cap of $53.64M.
What is the 52-week high for PULMONX CORP stock?
The PULMONX CORP 52-week high stock price is $3.88.
What is the 52-week low for PULMONX CORP stock?
The PULMONX CORP 52-week low stock price is $1.13.
Can I buy LUNG shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy LUNG shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in LUNG on Stake
- Buy LUNG from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of LUNG from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
LUNG related stocks